These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27757529)

  • 21. Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy.
    Giacobbe DR; Del Bono V; Coppo E; Marchese A; Viscoli C
    Microb Drug Resist; 2015 Jun; 21(3):342-4. PubMed ID: 25514440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model.
    Knappe D; Fritsche S; Alber G; Köhler G; Hoffmann R; Müller U
    J Antimicrob Chemother; 2012 Oct; 67(10):2445-51. PubMed ID: 22729924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESBL-producing Escherichia coli isolated from bloodstream infections--antimicrobial susceptibility, conjugative transfer of resistance genes and phylogenetic origin.
    Franiczek R; Krzyżanowska B
    Adv Clin Exp Med; 2014; 23(6):865-70. PubMed ID: 25618110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PK-PD modeling of β-lactam antibiotics: in vitro or in vivo models?
    de Araujo BV; Diniz A; Palma EC; Buffé C; Dalla Costa T
    J Antibiot (Tokyo); 2011 Jun; 64(6):439-46. PubMed ID: 21505469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli.
    Preston SL; Briceland LL
    Ann Pharmacother; 1993; 27(7-8):870-3. PubMed ID: 8364266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in rodents challenged with LPS or E. coli bacteria.
    Kung AH; Ammons WS; Lin Y; Kohn FR
    Prog Clin Biol Res; 1994; 388():255-63. PubMed ID: 7831363
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
    Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of starvation-induced lysosomal activity in Saccharomyces cerevisiae.
    Yoon J; Chang ST; Park JS; Kim YH; Min J
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):283-9. PubMed ID: 20632003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
    Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
    To KK; Lo WU; Chan JF; Tse H; Cheng VC; Ho PL
    Int J Infect Dis; 2013 Feb; 17(2):e120-4. PubMed ID: 23098812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivo.
    Jung E; Feldhoff RC; Walz BM; Drehs MM; Buchheit JQ; Lassiter HA
    Am J Med Sci; 1998 May; 315(5):307-13. PubMed ID: 9587087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
    Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model.
    Sohn DW; Han CH; Jung YS; Kim SI; Kim SW; Cho YH
    Int J Antimicrob Agents; 2009 Sep; 34(3):215-9. PubMed ID: 19375896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
    Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
    Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.